Literature DB >> 29299725

20-year risk of breast cancer recurrence.

Karel Kostev1,2, Matthias Kalder3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29299725     DOI： 10.1007/s10549-017-4636-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  4 in total

1.  Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries.

Authors:  Rikke Nørgaard Pedersen; Buket Öztürk; Lene Mellemkjær; Søren Friis; Trine Tramm; Mette Nørgaard; Deirdre P Cronin-Fenton
Journal:  Clin Epidemiol       Date:  2020-10-14       Impact factor: 4.790

2.  Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.

Authors:  Nina Gran Egeland; Marie Austdal; Bianca van Diermen-Hidle; Emma Rewcastle; Einar G Gudlaugsson; Jan P A Baak; Ivar Skaland; Emiel A M Janssen; Kristin Jonsdottir
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

3.  Experimental models of endocrine responsive breast cancer: strengths, limitations, and use.

Authors:  Robert Clarke; Brandon C Jones; Catherine M Sevigny; Leena A Hilakivi-Clarke; Surojeet Sengupta
Journal:  Cancer Drug Resist       Date:  2021-07-08

4.  The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.

Authors:  Rikke Nørgaard Pedersen; Buket Öztürk Esen; Lene Mellemkjær; Peer Christiansen; Bent Ejlertsen; Timothy Lee Lash; Mette Nørgaard; Deirdre Cronin-Fenton
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 13.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.